- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 3/00 - Drugs for disorders of the metabolism
Patent holdings for IPC class A61P 3/00
Total number of patents in this class: 7025
10-year publication summary
|
258
|
242
|
392
|
467
|
471
|
564
|
511
|
526
|
494
|
217
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
282 |
| F. Hoffmann-La Roche AG | 7926 |
66 |
| Bristol-myers Squibb Company | 4892 |
57 |
| Takeda Pharmaceutical Company Limited | 2704 |
56 |
| Boehringer Ingelheim International GmbH | 4704 |
55 |
| Janssen Pharmaceutica N.V. | 3423 |
54 |
| Novartis AG | 10904 |
47 |
| Amicus Therapeutics, Inc. | 346 |
45 |
| The Trustees of the University of Pennsylvania | 4308 |
41 |
| Modernatx, Inc. | 1260 |
40 |
| Société des Produits Nestlé S.A. | 9208 |
39 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
38 |
| Pfizer Inc. | 3367 |
37 |
| Eli Lilly and Company | 3814 |
37 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3126 |
33 |
| sanofi-aventis | 374 |
33 |
| Amgen Inc. | 4047 |
32 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 820 |
32 |
| The Regents of the University of California | 19812 |
30 |
| Genzyme Corporation | 1233 |
30 |
| Other owners | 5941 |